C. Tani

Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.

F. Carrilho, P. Hoff, H. de Andrade Carvalho, 2021, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival

F. Carrilho, P. Hoff, A. Chagas, 2016 .

Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?

F. Carrilho, N. Horvat, E. Abdala, 2021, European journal of gastroenterology & hepatology.

The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib.

F. Carrilho, P. Hoff, A. Chagas, 2017, Annals of hepatology.

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage

F. Carrilho, A. Chagas, M. Diniz, 2017, Clinics.

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases

V. Alves, F. Carrilho, A. Chagas, 2015, Clinics.

Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort

A. S. Lima, F. Carrilho, F. Piñero, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients

F. Carrilho, C. Oliveira, V. Ratziu, 2014, American journal of clinical oncology.

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement

F. Carrilho, F. Carnevale, M. Menezes, 2020, Clinics.